Think biotech won’t affect you? Think again. This program fast-forwards you 5- 10 years into the future, revealing how converging technologies are reshaping our world—and helps you build the mindset to spot unexpected, game-changing opportunities before anyone else.
The Future of Biotech is not a summit or a conference—it’s a learning program. Designed with the same rigor and curriculum design as our flagship Executive Program, it offers a deep, focused lens into one of the most transformative technologies of our time. This experience isn’t about passive listening. It’s about actively shifting your mindset, helping you understand not just what’s happening in biotech, but how to think about it—and why it matters for your business, your industry, and society at large. Our goal is to help you see the possible futures, so you can lead—not follow—what comes next.
Program topics
Our lens: Biology is now data. We can read, write, and reprogram life itself.
Why it matters:
Our lens: Nature is the ultimate engineer—and we’re finally learning to build like it.
Why it matters:
Our lens: The brain is the next frontier of performance and design.
Why it matters:
Our lens: DNA is code—and we’re rewriting what life can do.
Why it matters:
Our lens: Biotech is the next big wave—quietly rewriting the rules.
Why it matters:
Join us if you're ready to see what's next—before the rest of the world does.
Biotechnology is following the same exponential trajectory as the digital revolution, but with even greater economic potential. Learn why biology is becoming the next foundational platform technology and how it will transform every major industry, from manufacturing and agriculture to computing and materials. Gain the frameworks needed to identify the highest-potential opportunities emerging from this shift.
The wider world is finally realizing that superhuman AI will likely arrive by the end of the 2020s. Now that we have more clarity about the roadmap to artificial general intelligence, it’s time to unite inspiring visions with concrete plans for harnessing AGI in the life sciences. So how, practically, will this transform medicine and human health? Discover key emerging technologies that will harness AGI to revolutionize patient care and personal wellness over the coming decade—from robotic surgeons to wearable smart sensors, printable organs, and brain-computer interfaces. Learn how advanced biosimulation will unlock breakthrough cures and untangle the mysteries of aging. And see how all this convergent exponential progress will propel humanity toward longevity escape velocity in the 2030s. Yet computation alone cannot solve biology or defeat major diseases. We’ll explore how innovators in wet-lab science, clinical care, policymaking, law, ethics, and investing also have crucial roles to play over these pivotal years to achieve the healthy, flourishing future every person deserves.
This session explores how biomimicry unlocks innovation by asking: “How has nature solved this?”—and applying those answers to systems, structures, and strategy.
From thought-controlled devices to cognition-boosting environments, this session reveals how neuroscience is reshaping productivity, learning, and wellbeing—alongside the ethical dilemmas it brings.
This session explores how biological principles like self-renewal and low-energy processing could solve computing’s biggest challenges in energy, heat, and resilience.
Biotechnology is transforming food, health, and environmental solutions, much like chemistry did in the last century. With advancements in DNA sequencing, synthesis, and computational biology, anyone can now develop and market biological innovations faster than ever. And as consumer sentiment around GMOs evolves, biotech innovators can build great products people want by focusing on sustainability, transparency, and clear benefits. This talk explores how to leverage biotech to create products that align with consumer values while delivering clear benefits they're willing to pay for.
Need assistance? Our programs team is here to help! For payment questions, or if you need vendor registration, email programs@su.org.
Attending as a group? Email programs@su.org for exclusive pricing.
Unlock the FULL transformative program with unparalleled access to all sessions, unparalled access experts and participation in 3 hands-on workshops to fully expand your knowledge.
3 Hands-on Workshops to help turn the hypothetical into practical
Access to our Global Alumni Network. Including Member matching
Digital Credential to add to your resume/Linkedin
Access to 17 hours of virtual programming from anywhere in the world.
Recordings of the days sessions will be available by Midnight PT each day
Get to know a few of the experts who will be presenting at the event. More experts will be announced closer to the program.
.webp)
Eriona Hysolli completed her PhD work at Yale University working on derivation and characterization of human induced pluripotent stem cells and the role of micro RNAs during reprogramming. She then went on to do postdoctoral training in George Church’s lab where she published studies on Genomically recoded bacteria - mammalian co- culture systems, multiplex genome engineering approaches for human genome recoding. Furthermore, in his laboratory she derived the first reprogrammed African elephant iPSCs and led the woolly mammoth de-extinction efforts, work that she carried forward at Colossal Biosciences as head of biological sciences. There she led the efforts to de-extinct the woolly mammoth, working on Proboscidean comparative genomics and reference genome assemblies, multiplex editing in embryo for de-extinction, Asian elephant iPSC derivation and stem cell technologies, as well as biobanking efforts for elephant conservation. In 2023, she was selected as one of Time100 Next luminaries for her work on mammoth de-extinction.
John-Clark Levin is research lead for Google AI visionary Ray Kurzweil. At Kurzweil Technologies, he conducts foresight about the roadmap to artificial superintelligence, including focus on applications to the life sciences.
Reynolds has spent much of her career in two different worlds that both center their business around foresight. Whether working with scientists at NASA Jet Propulsion Laboratory or strategists at BMW Designworks, she has used design to create new pathways and find untapped opportunities in new and non-traditional places.
Dimitri Deheyn is in the Marine Biology Research Division at Scripps Institution of Oceanography, University of California, San Diego. Deheyn is a marine biologist who has been studying ecotoxicology for more than six years. Originally from Belgium, he received B.S., M.S., and Ph.D. degrees at the Free University of Brussels where he first became involved in research on marine organisms producing bioluminescence.
Dr. Daniel Wangpraseurt is an interdisciplinary marine biologist whose research bridges coral reef science, engineering, and biophysics. He leads the Coral Reef Ecophysiology and Engineering Lab at Scripps and also serves as the co-founder of Hybrid Reef Solutions, a startup that aims to address the need for effective and sustainable solutions to protect coral reefs.
Keolu Fox Ph.D., Kānaka Maoli (Native Hawaiian) is an assistant professor at University of California, San Diego. Dr. Fox’s multi-disciplinary research interests include genome sequencing, genome engineering, computational biology, evolutionary genetics, paleogenetics, and Indigenizing biomedical research.
Ying grew up in Las Vegas and discovered her love for plants when she moved from the desert to California. She earned her Ph.D. at Stanford, studying the genomics and physiology of salt and heavy metal tolerant extremophytes. As a postdoc at the Salk Institute, she identified genes related to altering root morphology to engineer bigger, deeper roots that capture carbon for the Harnessing Plants Initiative. She has traveled all around the world observing how plants adapt to extreme environments, and loves weird and wacky plants! Ying is passionate about harnessing the power of Rare Flora to pave the way for a climate-resilient future, where plants, people, and our planet thrive together. Phytomining, an eco-friendly approach, has tremendous potential to revolutionize our impact on the environment.
Dr. Haven Baker is a co-founder of Pairwise, a technology company pioneering the application of gene editing (CRISPR) in plant breeding. Accomplishments include a significant number of technology and research deals with academic and commercial entities including Harvard, Broad Institute, Mass General Hospital, Bayer, and a range of other ag companies.
Visionary entrepreneur Naveen Jain founded Moon Express, Viome & InfoSpace, tackling humanity's greatest challenges through bold innovation in health, space & education. Ernst & Young Entrepreneur of the Year & UN Humanitarian Innovation Award recipient.
Entrepreneur at agriculture & tech's frontier. Grew Comex-McKinnon to €203M, founded Cainthus (livestock AI). Advises US DOE & EU on agri-tech. Sought-after speaker on smart farming's future.
Venture design leader with 20+ years building regenerative, circular, and humane tech ventures. Executive at IDEO, Singularity University & Planet Home. Co-Founder of REUSEFUL. CMU BFA + ASU MS Biomimicry.
Philosopher & cultural analyst, VP of Research at Singularity University. Expert in AI ethics, algorithmic bias & exponential tech. Empowering leaders to build equitable, responsible AI systems for a better future.
Neuroscientist & behavioural strategist helping leaders harness brain science for AI adoption, digital transformation & high-performance cultures. Head of Consulting, Future Academy X | Partner, NeuroPower Group.
Researcher, writer & consultant with 10+ years in Silicon Valley. Ex-Principal Faculty at Singularity University, advising EY, Sony & FC Barcelona on emerging tech. Oxford MBA. Featured in Wired, Forbes & Vice.
Past Attendee
Past Attendee
Past Attendee
Founder of Cathartic Clarity✨
Past Attendee
Previous Attendee
Previous Attendee
Founder of Cathartic Clarity✨
Past Attendee
Client
Past Attendee
Past Attendee
Past Attendee
Past Attendee
Past Attendee
Previous Attendee
Previous Attendee
Founder of Cathartic Clarity✨
Past Attendee
Past Attendee
Founded in 2008 by renowned futurists Ray Kurzweil & Peter Diamandis, Singularity exists to help individuals, organizations, and governments transform the way they lead, think, and create the future.
We're focused on the convergence and application of exponential technologies to deliver business and societal value. Our unique approach to exponential thinking and technology takes a zoom in - zoom out approach. The Singularity perspective examines technologies through the lens of their applications on an individual, organizational, and societal level. Pairing this perspective with our tools and frameworks gives leaders a new mindset and lens to see the world through.
